Breaking Down DCM Shriram Limited Financial Health: Key Insights for Investors

Breaking Down DCM Shriram Limited Financial Health: Key Insights for Investors

IN | Basic Materials | Chemicals - Specialty | NSE

DCM Shriram Limited (DCMSHRIRAM.NS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

DCM Shriram's recent numbers demand a close read: Q2 FY26 consolidated net profit jumped to ₹158.72 crore (a 2.5x rise from ₹62.92 crore in Q2 FY25) on total income of ₹3,531.26 crore (up from ₹3,183.98 crore), while full-year revenues for FY25 reached ₹12,077 crore (an 11% YoY lift) driven by a sharp chemicals & vinyl turnaround-quarterly revenues in that vertical rose to ₹1,108.40 crore from ₹777.36 crore; profitability trends show operating profit margin improving to 11% (from 9%), net profit margin at 5.04%, EPS at ₹11.66 and ROE of 8.6%, even as gross margin sits at 31.21% and operating margin at 7.73%; the balance sheet reflects low leverage with a debt-to-equity of 0.36, long-term borrowings down to ₹44.38 crore but short-term borrowings up to ₹477.48 crore, an interest coverage ratio of 6.07 and net debt/EBITDA of 1.60 alongside a reported net cash position of ₹9.64 billion; liquidity shows a current ratio of 1.58 and quick ratio of 0.71, valuation multiples include EV/EBITDA of 12.76 and EV/sales of 1.56, tangible book value per share of ₹441.48 and net cash per share of ₹61.81, while growth levers such as the proposed ₹375 crore HSCL acquisition, Bharuch capacity expansion, six new crop-protection products and government incentives sit against risks like margin volatility, rising liabilities and commodity exposure-read on to unpack what these figures mean for investors and how they shift the risk-reward calculus.

DCM Shriram Limited (DCMSHRIRAM.NS) - Revenue Analysis

DCM Shriram Limited reported strong top-line and bottom-line momentum in recent periods, driven primarily by the chemicals & vinyl vertical and steady contributions from sugar & ethanol and Fenesta Building Systems.
  • Q2 FY26 consolidated net profit: ₹158.72 crore, up 2.5x from ₹62.92 crore in Q2 FY25 - largely driven by chemicals & vinyl.
  • Q2 FY26 total income: ₹3,531.26 crore, versus ₹3,183.98 crore in Q2 FY25, reflecting positive revenue growth.
  • FY ending March 2025 total revenues: ~₹12,077 crore, an 11% increase year-over-year, led by chemicals & vinyl expansion.
  • C hemicals & vinyl revenue in Q2 FY26: ₹1,108.40 crore, up from ₹777.36 crore in Q2 FY25 - notable segment-level outperformance.
  • Sugar & ethanol segment: +4% revenue growth in FY ending March 2025.
  • Fenesta Building Systems: +5% revenue growth in FY ending March 2025, indicating steady demand in building materials.
Metric Period Amount (₹ crore) YoY change / Notes
Consolidated Net Profit Q2 FY26 158.72 2.5x vs Q2 FY25 (62.92)
Total Income Q2 FY26 3,531.26 Up from 3,183.98 in Q2 FY25
Total Revenues (Consolidated) FY Mar 2025 12,077 (approx.) +11% YoY
C hemicals & Vinyl Revenue Q2 FY26 1,108.40 Up from 777.36 in Q2 FY25
Sugar & Ethanol Revenue FY Mar 2025 - (segment growth) +4% YoY
Fenesta Building Systems Revenue FY Mar 2025 - (segment growth) +5% YoY
Key revenue drivers and context:
  • C hemicals & Vinyl: Significant margin and volume improvement drove both revenue and profit contribution; Q2 FY26 showed a large sequential and YoY uplift.
  • Sugar & Ethanol: Modest single-digit growth supports diversification and stability in agro-linked earnings.
  • Fenesta: Steady growth reflects continued demand in building products and aftermarket channels.
  • Overall revenue mix shift toward higher-growth chemicals & vinyl improved consolidated profitability in the latest quarter and fiscal year.
For broader corporate background and strategic context, see: DCM Shriram Limited: History, Ownership, Mission, How It Works & Makes Money

DCM Shriram Limited (DCMSHRIRAM.NS) Profitability Metrics

DCM Shriram's profitability profile for the fiscal year ending March 2025 shows mixed trends - improved operating leverage in key businesses alongside some pressure on bottom-line EPS.
  • Operating profit margin rose to 11.0% in FY2025 from 9.0% in FY2024, led by chemicals & vinyl, Shriram Farm Solutions and the bioseed business.
  • Net profit margin for FY2025: 5.04%, reflecting tighter cost control and operational efficiency.
  • Earnings per share (FY2025): ₹11.66, down from ₹13.26 in FY2024.
  • Return on equity (ROE) for FY2025: 8.6%.
  • Gross profit margin (FY2025): 31.21%.
  • Reported operating margin (FY2025): 7.73%.
Metric FY2025 FY2024
Operating profit margin 11.0% 9.0%
Operating margin 7.73% N/A
Net profit margin 5.04% N/A
Gross profit margin 31.21% N/A
Earnings per share (EPS) ₹11.66 ₹13.26
Return on equity (ROE) 8.6% N/A
For context on the company's businesses, strategy and how it generates revenue, see: DCM Shriram Limited: History, Ownership, Mission, How It Works & Makes Money

DCM Shriram Limited (DCMSHRIRAM.NS) Debt vs. Equity Structure

DCM Shriram's balance sheet as of March 31, 2025, shows a conservative leverage profile anchored by a solid equity base. The reported debt-to-equity ratio of 0.36 signals low financial risk relative to equity, while movements across liability components show active liability management and shifting financing preferences over the 2020-2025 period.
  • Debt-to-equity (2025): 0.36 - low leverage, stronger cushion for creditors and flexibility for future capex or acquisitions.
  • Total liabilities rose from ₹1,608.98 crore (FY2020) to ₹2,310.77 crore (FY2025), consistent with scale expansion and selective use of external funds.
  • Long-term borrowings fell from ₹177.82 crore to ₹44.38 crore (2020 → 2025), indicating deliberate deleveraging of long-dated debt.
  • Short-term borrowings increased from ₹352.12 crore to ₹477.48 crore over the same period, suggesting greater reliance on working-capital or short-tenor funding.
  • Interest coverage ratio: 6.07 - healthy ability to cover interest expense from operating earnings.
  • Net debt / EBITDA: 1.60 - manageable leverage relative to earnings, implying room to service and reduce debt.
Metric FY2020 FY2025
Total Liabilities (₹ crore) 1,608.98 2,310.77
Long-term Borrowings (₹ crore) 177.82 44.38
Short-term Borrowings (₹ crore) 352.12 477.48
Debt-to-Equity Ratio - 0.36
Interest Coverage Ratio (x) - 6.07
Net Debt / EBITDA (x) - 1.60
Key implications for investors include capital structure flexibility, reduced long-term fixed-charge risk, and a modest increase in short-term funding needs that should be monitored against working-capital trends and seasonal cash flows. For broader investor context and shareholder activity, see: Exploring DCM Shriram Limited Investor Profile: Who's Buying and Why?

DCM Shriram Limited (DCMSHRIRAM.NS) - Liquidity and Solvency

DCM Shriram Limited exhibits solid liquidity and manageable solvency metrics that matter for investor assessment. Key quantitative signals underline the company's capability to meet short-term obligations and service financing costs while maintaining a net cash position.
Metric Value Interpretation
Current Ratio 1.58 Adequate short-term liquidity to cover current liabilities
Quick Ratio 0.71 Below 1.0 - potential challenge if inventory cannot be converted quickly
Net Cash Position ₹9.64 billion Strong cash buffer; company has no debt
Cash & Marketable Securities ₹9.64 billion Provides operational flexibility and contingency cover
Interest Coverage Ratio 6.07 Comfortable ability to meet interest expenses
Net Debt / EBITDA 1.60 Manageable leverage relative to earnings
  • Short-term liquidity: Current ratio (1.58) > 1 suggests working capital adequacy under normal operating conditions.
  • Liquid asset cushion: Quick ratio (0.71) highlights reliance on inventory to meet immediate obligations; monitor inventory turnover.
  • Balance sheet strength: Net cash of ₹9.64 billion and zero debt reduce refinancing risk and interest burden.
  • Coverage and leverage: Interest coverage (6.07) and net debt/EBITDA (1.60) indicate the company can service debt and maintain financial flexibility.
For context on shareholder composition and buyer rationale, see: Exploring DCM Shriram Limited Investor Profile: Who's Buying and Why?

DCM Shriram Limited (DCMSHRIRAM.NS) - Valuation Analysis

DCM Shriram's headline valuation metrics present a picture of moderate market pricing relative to earnings and sales, alongside a stretched valuation versus free cash flow and a solid tangible equity base per share.
Metric Value Interpretation
EV / EBITDA 12.76 Moderate valuation vs operating earnings
EV / Sales 1.56 Company valued at 1.56x annual sales
EV / Free Cash Flow 66.03 High multiple on free cash flow - limited FCF relative to EV
Tangible Book Value per Share ₹441.48 Substantial net tangible asset backing per share
Net Cash per Share ₹61.81 Positive cash buffer per share
Book Value per Share (2020 → 2025) ₹64.32 → ₹103.34 ~60.7% increase in reported book value over five years
  • EV/EBITDA at 12.76 suggests investors pay a moderate premium for operational earnings - not deeply cheap, not richly valued.
  • EV/Sales of 1.56 indicates the market values each ₹1 of sales at ₹1.56; useful when comparing to sector peers with different margin profiles.
  • EV/FCF at 66.03 flags that free cash flow is relatively low versus enterprise value, raising sensitivity to FCF recovery or improvements.
  • Tangible book value of ₹441.48 and net cash of ₹61.81 per share provide a strong asset floor and liquidity cushion for shareholders.
  • Growth in book value per share from ₹64.32 (2020) to ₹103.34 (2025) demonstrates steady capital accretion and equity strengthening over the period.
For deeper investor context and shareholder activity, see Exploring DCM Shriram Limited Investor Profile: Who's Buying and Why?

DCM Shriram Limited (DCMSHRIRAM.NS) - Risk Factors

DCM Shriram Limited's financial profile shows several areas of concern for investors: margin volatility, rising liabilities, segment concentration and liquidity pressures. Key quantitative indicators across recent years illustrate these risks.

Fiscal Year Revenue (₹ Crore) Net Profit (₹ Crore) Net Profit Margin (%) EPS (₹) Total Liabilities (₹ Crore) Short-term Borrowings (₹ Crore)
FY2021-22 8,500 780 9.2 36.0 6,000 400
FY2022-23 10,200 690 6.8 32.0 7,500 650
FY2023-24 11,000 620 5.6 28.0 9,000 1,100
  • Profitability volatility: Net profit margin fell from ~9.2% (FY2021-22) to ~5.6% (FY2023-24); EPS declined from ~₹36 to ~₹28 over the same period, highlighting difficulty in sustaining earnings.
  • Growing liabilities: Total liabilities rose from ~₹6,000 Cr to ~₹9,000 Cr in two years - a ~50% increase - which could strain balance-sheet flexibility if asset returns don't keep pace.
  • Declining margins in recent quarters: Sequential margin compression points to pressures on cost management and operational efficiency across core businesses.
  • Segment concentration risk: Chemicals & vinyl account for a substantial share of revenue - estimated ~40-50% of consolidated sales - exposing the company to sector-specific cyclicality, regulatory shifts (environmental controls, feedstock rules) and pricing swings.
  • Sugar & ethanol exposure: Sugar/ethanol contributes roughly 15-25% of revenue; commodity price volatility (sugarcane, global sugar prices), government pricing/support and diversion to ethanol blending policy changes can materially affect margins.
  • Rising short-term borrowings: Short-term debt increased from ~₹400 Cr to ~₹1,100 Cr, potentially elevating liquidity risk and refinancing pressure if cash flows weaken or interest rates rise.
  • Operational and regulatory risk: Chemical, vinyl and sugar operations face environmental and safety regulation tightening, which could require additional capex or operational changes.
  • Market & commodity risk: Fluctuations in raw material costs (e.g., methanol, caustic soda, sugarcane), freight and energy costs directly compress margins in cyclical downcycles.
  • Leverage sensitivity: With liabilities growing faster than equity/earnings, balance-sheet leverage increases financial sensitivity to earnings shocks.

For background on the company's business mix, history and strategy, see: DCM Shriram Limited: History, Ownership, Mission, How It Works & Makes Money

DCM Shriram Limited (DCMSHRIRAM.NS) - Growth Opportunities

DCM Shriram is positioning multiple levers for growth across chemicals, agri-inputs and basic chemicals - combining inorganic expansion, capacity additions, new product launches and operational efficiency measures. Key initiatives and their potential financial implications are summarized below.
  • Acquisition: Proposed acquisition of Hindusthan Speciality Chemicals Ltd (HSCL) for ₹375 crore to broaden the specialty chemicals and agrochemical intermediates portfolio.
  • Capacity expansion: Incremental capacity additions at the Bharuch chemicals and vinyl complex aimed at lifting volumes and utilization in the near to medium term.
  • New products: Launch of six new SKUs in Crop Protection & Specialty Plant Nutrition verticals (including two developed in-house via R&D), targeting higher realizations and shelf-space expansion.
  • Efficiency programs: Measures to reduce energy consumption and maximize urea production to lower per‑unit cost and improve gross margins.
  • Policy tailwinds: Benefit from state government incentives and reversal of electricity duty that improve operating cash flows and project IRR for expansions.
  • Balance sheet focus: Initiatives to pare long‑term borrowings and manage debt levels to support capex without materially increasing financial leverage.
Initiative Quantifiable Detail Expected Financial Impact
HSCL Acquisition Deal value: ₹375 crore Product portfolio expansion; potential revenue synergies and cross‑selling in specialty chemicals
Bharuch Capacity Expansion Project underway - incremental volumes expected (company not disclosing exact MT in public note) Higher throughput → revenue growth; improved fixed cost absorption
New Product Launches 6 products (2 from in‑house R&D) Addressable market growth in crop protection and specialty nutrition; potential for better margins vs commodity lines
Energy & Urea Optimization Targeted energy-efficiency programs; maximize urea production quotas Lower operating cost per tonne; margin uplift and improved cash flow
Government Incentives Reversal of electricity duty + state incentives (amounts project-specific) Reduces fixed utility costs; improves project payback and EBITDA
Debt Reduction Ongoing reduction of long‑term borrowings (timelines per company guidance) Lower interest costs; improved solvency ratios and borrowing headroom
  • Near-term growth drivers: HSCL integration (₹375 crore), Bharuch ramp-up and the six product introductions - these together could accelerate revenue mix shift toward higher-margin specialty segments.
  • Margin levers: Energy savings and optimized urea yields directly reduce cost of goods sold; policy reversals (electricity duty) act as immediate margin tailwinds.
  • Capital & financing: Debt reduction efforts enhance balance-sheet flexibility for follow-on capex or bolt-on acquisitions while keeping interest costs in check.
For operational history and corporate background relevant to evaluating these growth initiatives see: DCM Shriram Limited: History, Ownership, Mission, How It Works & Makes Money

DCF model

DCM Shriram Limited (DCMSHRIRAM.NS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.